demonstrated that silencing PD‐L1 in aggressive HCC cell lines significantly inhibited DNMT1 expression, accompanied by global DNA hypomethylation and dysregulation of the tumour stem cell marker EpCAM.255. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.